Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MHP 133 is a drug with multiple CNS targets(AChE with Ki of 69 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | MHP 133 is a drug with multiple CNS targets(AChE with Ki of 69 μM). |
Targets&IC50 | AChE:ki:69 μM |
In vitro | MHP-133 exhibits this nicotinic-like activity in the cell line. MHP-133 produces a bi-phasic effect on slice survival, particularly in the dentate gyrus and the CA1 regions[1]. |
In vivo | MHP-133 (50, 100, or 200 μg/kg, i.p.) enhances acquisition of the task and increases task accuracy In rats, elicits significant improvements in task accuracies during sessions initiated 10 min after dosing[1]. |
Molecular Weight | 377.83 |
Formula | C17H20ClN5O3 |
CAS No. | 147340-43-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MHP 133 147340-43-0 Neuroscience AChR MHP-133 MHP133 inhibitor inhibit